Perinatal Arterial Stroke Treated With Stromal Cells Intranasally (PASSIoN)
Adult Mesenchymal Stromal Cells to Regenerate the Neonatal Brain: the PASSIoN Trial (Perinatal Arterial Stroke Treated With Stromal Cells IntraNasally)
Sponsor: M.D. Anderson Cancer Center
A PHASE1/PHASE2 clinical study on Neonatal Stroke and Perinatal Arterial Ischemic Stroke, this trial is completed. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 11 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Nov 2021 — Jun 2024 [monthly]
Completed PHASE1_PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Dec 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Nov 2018 — Jun 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- The University of Texas Health Science Center at San Antonio
- UMC Utrecht
- ZonMw: The Netherlands Organisation for Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .